J3M-MC-JZQB app for iPhone and iPad

4.0 ( 1120 ratings )

Health & Fitness
Developer: Medable, Inc.

Free

Current version: 1.0, last update: 2 months ago
First release : 03 Jul 2024
App size: 100.35 Mb

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.